Direct-to-Consumer Antidepressant Advertising and Consumers' Optimistic Bias about the Future Risk of Depression: The Moderating Role of Advertising Skepticism

Health Communication

Volumn 29, Issue 6, 2014, Pages 586-597

  Park, Jin Seong ^a   Ju, Ilwoo ^b   Kim, Kenneth Eunhan ^b  

^a UNIVERSITY OF TENNESSEE   (United States)

^b OKLAHOMA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

ADOLESCENT; ADULT; ADVERTIZING; AGED; ATTITUDE TO HEALTH; DEPRESSION; FEMALE; HUMAN; MALE; MIDDLE AGED; PROCEDURES; PSYCHOLOGY; RISK FACTOR; STATISTICAL BIAS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; ADVERTISING AS TOPIC; AGED; AGED, 80 AND OVER; ANTIDEPRESSIVE AGENTS; ATTITUDE TO HEALTH; BIAS (EPIDEMIOLOGY); DEPRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; YOUNG ADULT;

EID: 84897983164     PISSN: 10410236     EISSN: 15327027     Source Type: Journal    
DOI: 10.1080/10410236.2013.785318     Document Type: Article

References (65)

1. Aiken, L. S., & West, S. G. (1991). Multiple regression: Testing and interpreting interactions. Thousand Oaks, CA: Sage.
2. An, S. (2008). Antidepressant direct-to-consumer advertising and social perception of the prevalence of depression: Application of the availability heuristic. Health Communication, 23, 499-505.
3. Baron, R. M., & Kenny, D. A. (1986). The moderator-mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations. Journal of Personality and Social Psychology, 14, 178-184.
4. Bell, R. A., Wilkes, M. S., & Kravitz, R. L. (2000). The educational value of consumer-targeted prescription drug print advertising. Journal of Family Practice 49, 1092-1098.
5. Beltramini, R. (2006). Consumer believability of information in direct-to-consumer advertising of prescription drugs. Journal of Business Ethics, 63, 333-343.
6. Blankenhorn, K., Duckwitz, N., & Kerr, M. (2001). Power to the people. Medical Marketing & Media, 36(8), 66-70.
7. Block, L. G., & Keller, P. A. (1998). Beyond protection motivation: An investigative theory of health appeals. Journal of Applied Social Psychology, 28, 1584-1608.
8. Calfee, J. E., & Ringold, D. J. (1994). The 70% majority: Enduring consumer beliefs about advertising. Journal of Public Policy & Marketing, 13, 228-238.
9. Cohen, J. (1988). Statistical power analysis for the behavioural sciences (2nd ed.). New York, NY: Academic Press.
10. Covey, J. A., & Davies, A. D. M. (2004). Are people unrealistically optimistic? It depends how you ask them. British Journal of Health Psychology, 9, 39-49.
11. DeLorme, D. E., Huh, J., & Reid, L. N. (2009). Direct-to-consumer advertising skepticism and the use and perceived usefulness of prescription drug information sources. Health Marketing Quarterly, 26, 293-314.
12. Diehl, S., Mueller, B., & Terlutter, R. (2007). Skepticism toward pharmaceutical advertising in the U.S. and Germany. Cross-Cultural Buyer Behavior: Advances in International Marketing, 18, 31-60.
13. Doney, P. M., Cannon, J. P., & Mullen, M. R. (1998). Understanding the influence of national culture on the development of trust. Academy of Management Review, 23, 601-620.
14. Donohue, J. M., & Berndt, E. R. (2004). Effects of direct-to-consumer advertising on medication choice: The case of antidepressants. Journal of Public Policy & Marketing, 23, 115-127.
15. Donohue, J. M, Berndt, E., R., Rosenthal, M., Epstein, A. M., & Frank, R. G. (2004). Effects of pharmaceutical promotion on adherence to the treatment guidelines for depression. Medical Care, 42, 1176-1185.
16. Donohue, J. M., Cevasco, M., & Rosenthal, M. B. (2007). A decade of direct-to-consumer advertising of prescription drugs. New England Journal of Medicine, 357, 673-681.
17. Eiser, J. R., & Cole, N. (2002). Participation in cervical screening as a function of perceived risk, barriers and need for cognitive closure. Journal of Health Psychology, 7, 99-105.
18. Fogg, B. J., Lee, E., & Marshall, J. (2002). Interactive technology and persuasion. In J. P. Dillard & M. Pfau (Eds.), The persuasion handbook: Theory and practice (pp. 765-788). Thousand Oaks, CA: Sage.
19. Goff, V. V. (2002). Depression: A decade of progress, more to do. National Health Policy Forum Issue Brief, 786, 1-14.
20. Gonzalez, H. M., Vega, W. A., Williams, D. R., Tarraf, W., West, B. T., & Neighbors, H. W. (2010). Depression in the United States: Too little or too few. Archives of General Psychiatry, 67, 37-46.
21. Green, J. S., Grant, M., Hill, K. L., Brizzolara, J., & Belmont, B. (2003). Heart disease risk perception in college men and women. Journal of American College Health, 51, 207-211.
22. Grow, J. M., Park, J., & Han, X. (2006). Your life is waiting: Symbolic meanings in direct-to-consumer antidepressant advertising. Journal of Communication Inquiry, 30, 163-188.
23. Hair, J. F., Anderson, R. E., Tatham, R. L., & Black, W. C. (1998). Multivariate data analysis. Upper Saddle River, NJ: Prentice Hall.
24. Huh, J., DeLorme, D. E., & Reid, L. N. (2005). Factors affecting trust in on-line prescription drug information and impact of trust on behavior following exposure to DTC advertising. Journal of Health Communication, 10, 711-731.
25. Kaiser Family Foundation. (2008). Public views of direct-to-consumer prescription drug advertising. Retrieved from http://www.kff.org/kaiserpolls/upload/7774.pdf
26. Kaphingst, K. A., Rudd, R. E., DeJong, W., & Daltroy, L. H. (2004). Literacy demands of product information intended to supplement television direct-to-consumer prescription drug advertisements. Patient Education & Counseling, 55, 293-300.
27. Kaphingst, K. A., Rudd, R. E., DeJong, W., & Daltroy, L. H. (2005). Comprehension of information in three direct-to-consumer television prescription drug advertisements among adults with limited literacy. Journal of Health Communication, 10, 609-619.
28. Keller, M. B., McCullough, J. P., Klein, D. N. Arnow, B., Dunner, D. L., Gelenberg, A. J. Zajecka, J. (2000). A comparison of nefazodone, the cognitive-behavioral analysis system of psychotherapy, and their combination for the treatment of chronic depression. New England Journal of Medicine, 342, 1462-1470.
29. Kessler, R. C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K. R., Wang, P. S. (2003). The epidemiology of major depressive disorder: Results from the National Comorbidity Survey Replication (NCS-R). Journal of American Medical Association, 289, 3095-3105.
30. Kravitz, R. L., Epstein, R. M., Feldman, M. D., Franz, C. E., Azari, R., Wilkes, M. S., Franks, P. (2005). Influence of patients' requests for direct-to-consumer advertised antidepressants: A randomized controlled trial. Journal of the American Medical Association, 293, 1995-2002.
31. Larwood, L. (1978). Swine flu: A field study of self-serving biases. Journal of Applied Social Psychology, 8, 283-289.
32. Lee, A. L. (2009). Changing effects of direct-to-consumer broadcast drug advertising information sources on prescription drug requests. Health Communication, 24, 361-376.
33. Lipkus, I. M., Biradavolu, M., Fenn, K., Keller, P. A., & Rimer, B. A. (2001). Informing women about their breast cancer risks: Truth and consequences. Health Communication, 13, 205-226.
34. Lönnqvist, J. K. (2002). Psychiatric aspects of suicidal behavior: Depression. In K. Hawton & K. van Heeringen (Eds.), The international handbook of suicide and attempted suicide (pp. 107-120). Chichester, UK: Wiley.
35. MacInnis, D. J., & Jaworski, B. J. (1989). Information processing from advertisements: Toward an integrative framework. Journal of Marketing, 53(4), 1-23.
36. Mackert, M. (2011). Health literacy knowledge among direct-to-consumer pharmaceutical advertising professionals. Health Communication, 26, 523-533.
37. Macias, W, Springston, J. K., Lariscy, R. A. W., & Neustifter, B. (2007). A 13-year content analysis of survey methodology in communication-related journals. Journal of Current Issues and Research in Advertising, 30, 79-94.
38. Marcus, S. C., & Olfson, M. (2010). National trends in the treatment for depression: From 1998 to 2007. Archives of General Psychiatry, 67, 1265-1273.
39. Mastin, T., Andsager, J. L., Choi, J., & Lee, K. (2007). Health disparities and direct-to-consumer advertising: A content analysis of targeted magazine genres, 1992-2002. Health Communication, 22, 49-58.
40. Melillo, W. (2005). Drug cos. work to stave off legislation. AdWeek, 46(27), 6.
41. Mintzes, B., Barer, M. L., Kravitz, R. L., Kazanjian, A., Bassett, K., Lexchin, J., Marion, S. A. (2002). Influence of direct-to-consumer pharmaceutical advertising and patients' requests on prescribing decisions: Two site cross-sectional survey. British Medical Journal, 324, 278-279.
42. Morton, T. A., & Duck, J. M. (2001). Communication and health beliefs: Mass and interpersonal influences on perceptions on risk to self and others. Communication Research, 28, 602-626.
43. Myers, S. D., Royne, M. B., & Deitz, G. D. (2011). Direct-to-consumer advertising: Exposure, behavior, and policy implications. Journal of Public Policy and Marketing, 30, 110-118.
44. Nielsen Company. (2009). US ad spending fell 2.6% in 2008. Retrieved from http://blog.nielsen.com/nielsenwire/wp-content/uploads/2009/03/nielsen2008adspend-release.pdf
45. Obermiller, C., & Spangenberg, E. R. (1998). Development of a scale to measure consumer skepticism toward advertising. Journal of Consumer Psychology, 7, 159-186.
46. Olfson, M., & Marcus, S. C. (2009). National trends in antidepressant medication treatment. Archives of General Psychiatry, 66, 848-856.
47. Olfson, M., Marcus, S. C., Druss, B., Elinson, L., Tanielian, T., & Pincus, H. A. (2002). National trends in the outpatient treatment of depression. Journal of the American Medical Association, 287, 203-209.
48. Park, J., & Grow, J. M. (2008). The social reality of depression: DTC advertising of antidepressants and perceptions of the prevalence and lifetime risk of depression. Journal of Business Ethics, 79, 379-393.
49. Park, J., & Grow, J. M. (2010). Symptom information in direct-to-consumer antidepressant advertising and consumer perception of the lifetime risk of depression. Journal of Medical Marketing, 10, 123-133.
50. Peters, E., Lipkus, I., & Diefenbach, D. (2006). The functions of affect in health communications and in the construction of health preferences. Journal of Communication, 56, 140-162.
51. Pollay, R. W., & Mittal, B. (1993). Here's the beef: Factors, determinants, and segments in consumer criticism of advertising. Journal of Marketing, 57, 99-114.
52. Ranby, K. W., Aiken, L. S., Gerend, M. A., & Erchull, M. J. (2010). Perceived susceptibility measures are not interchangeable: Absolute, direct comparative, and indirect comparative risk. Health Psychology, 29, 20-28.
53. Rosenthal, R. (1991). Meta-analytic procedures for social research (rev.). Newbury Park, CA: Sage.
54. Rosenthal, M. B., Berndt, E. R., Donohue, J. M., Frank, R. G., & Epstein, A. M. (2002). Promotion of prescription drugs to consumers. New England Journal of Medicine, 346, 498-505.
55. Sheehan, K. B. (2003). Balancing acts: An analysis of Food and Drug Administration letters about direct-to-consumer advertising violations. Journal of Public Policy & Marketing, 22, 159-169.
56. Sheer, V. C., & Cline, R. J. (1994). The development and validation of a model explaining sexual behavior among college students: Implications for AIDS communication campaigns. Human Communication Research, 21, 280-304.
57. Sobel, M. E. (1982). Asymptotic confidence intervals for indirect effects in structural equation models. In S. Leinhardt (Ed.), Sociological methodology (pp. 290-312). Washington, DC: American Sociological Association.
58. Stapel, D., & Velthuijsen, A. (1996). 'Just as if it happened to me': The impact of vivid and self-relevant information on risk judgments. Journal of Social and Clinical Psychology, 15, 102-119.
59. Strine, T. W., Mokdad, A. H., Balluz, L. S., Gonzalez, O., Crider, R., Berry, J. T., & Kroenke, K. (2008). Depression and anxiety in the United States: findings from the 2006 Behavioral Risk Factor Surveillance System. Psychiatric Services, 59, 1383-1390.
60. TNS Media Intelligence (2011). Ad$pender. Retrieved from http://www.lib.utk.edu.proxy.lib.utk.edu:90/refs/business/adspender
61. Tyler, T. R., & Cook, F. L. (1984). The mass media and judgments of risk: Distinguishing impact on personal and societal level judgments. Journal of Personality and Social Psychology, 47, 693-708.
62. Weinstein, N. D. (1980). Unrealistic optimism about future life events. Journal of Personality and Social Psychology, 39, 806-820.
63. Weinstein, N. D. (1987). Unrealistic optimism about susceptibility to health problems: Conclusions from a community-wide sample. Journal of Behavioral Medicine, 10, 481-500.
64. Weinstein, N. D. (1989). Perceptions of personal susceptibility to harm. In V. M. Mays, G. W. Albee, & S. F. Schneider (Eds.), Primary prevention behavior (pp. 23-39). New York, NY: Plenum.
65. Zachry, W. M. III, Shepherd, M. D., Hinich, M. J., Wilson, J. P., Brown, C. M., & Lawson, K. A. (2002). Relationship between direct-to-consumer advertising and physician diagnosing and prescribing. American Journal of Health-System Pharmacy 59, 42-49.